[1]
|
施军平, 范建高. 脂肪性肝病诊疗规范化的专家建议(2019年修订版) [J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
|
[2]
|
Roychowdhury, S., Selvakumar, P.C. and Cresci, G.A.M. (2018) The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Medical Sciences (Basel, Switzerland), 6, Article No. 47. https://doi.org/10.3390/medsci6020047
|
[3]
|
Ma, J., et al. (2017) Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients, 9, Article No. 1124. https://doi.org/10.3390/nu9101124
|
[4]
|
中华医学会内分泌学分会. 非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版) [J]. 临床肝胆病杂志, 2018, 34(10): 2103-2108.
|
[5]
|
Kefala, G. and Tziomalos, K. (2019) Apoptosis Signal-Regulating Kinase-1 as a Therapeutic Target in Nonalcoholic Fatty Liver Disease. Expert Review of Gastroenter-ology & Hepatology, 13, 189-191.
https://doi.org/10.1080/17474124.2019.1570136
|
[6]
|
Safari, Z. and Gérard, P. (2019) The Links between the Gut Microbiome and Non-Alcoholic Fatty Liver Disease (NAFLD). Cellular and Molecular Life Sciences: CMLS, 76, 1541-1558. https://doi.org/10.1007/s00018-019-03011-w
|
[7]
|
Jasirwan, C.O.M., et al. (2016) The Role of the Gut Microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology, 13, 412-425. https://doi.org/10.1038/nrgastro.2016.85
|
[8]
|
Jandhyala, S.M., Talukdar, R., Subramanyam, C., et al. (2015) Role of the Normal Gut Microbiota. World Journal of Gastroenterology, 21, 8787-8803. https://doi.org/10.3748/wjg.v21.i29.8787
|
[9]
|
Ley, R.E., Turnbaugh, P.J., Klein, S., et al. (2006) Microbial Ecolo-gy: Human Gut Microbes Associated with Obesity. Nature, 444, 1022-1023. https://doi.org/10.1038/4441022a
|
[10]
|
Wang, Z., Klipfell, E., Bennett, B.J., et al. (2011) Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease. Nature, 472, 57-63. https://doi.org/10.1038/nature09922
|
[11]
|
Ley, R.E. (2010) Obesity and the Human Microbiome. Current Opinion in Gastroenterology, 26, 5-11.
https://doi.org/10.1097/MOG.0b013e328333d751
|
[12]
|
Qin, J., Li, Y., Cai, Z., et al. (2012) A Metagenome-Wide Association Study of Gut Microbiota in Type 2 Diabetes. Nature, 490, 55-60. https://doi.org/10.1038/nature11450
|
[13]
|
Murphy, E.F., Cotter, P.D., Hogan, A., et al. (2013) Divergent Metabolic Outcomes Arising from Targeted Manipulation of the Gut Microbiota in Diet-Induced Obesity. Gut, 62, 220-226. https://doi.org/10.1136/gutjnl-2011-300705
|
[14]
|
De Minicis, S., Rychlicki, C., Agostinelli, L., et al. (2014) Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice. Hepatology, 59, 1738-1749. https://doi.org/10.1002/hep.26695
|
[15]
|
Le Roy, T., Llopis, M., Lepage, P., et al. (2013) Intestinal Microbiota De-termines Development of Non-Alcoholic Fatty Liver Disease in Mice. Gut, 62, 1787-1794. https://doi.org/10.1136/gutjnl-2012-303816
|
[16]
|
Macpherson, A.J., et al. (2016) The Liver at the Nexus of Host-Microbial Interactions. Cell Host & Microbe, 20, 561-571.
https://doi.org/10.1016/j.chom.2016.10.016
|
[17]
|
Li, F., Duan, K., Wang, C., et al. (2016) Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterology Research and Practice, 2016, Article ID: 5491465. https://doi.org/10.1155/2016/5491465
|
[18]
|
Brown, C.T., Sharon, I., Thomas, B.C., et al. (2013) Genome Resolved Analysis of a Premature Infant Gut Microbial Community Reveals a Varibaculum Cambriense Genome and a Shift towards Fermentation-Based Metabolism during the Third Week of Life. Microbiome, 1, 30. https://doi.org/10.1186/2049-2618-1-30
|
[19]
|
The Human Microbiome Project Consortium (2012) Structure, Func-tion and Diversity of the Healthy Human Microbiome. Nature, 486, 207-214. https://doi.org/10.1038/nature11234
|
[20]
|
Paolella, G., Mandato, C., Pierri, L., et al. (2014) Gut-Liver Axis and Probiotics: Their Role in Non-Alcoholic Fatty Liver Disease. World Journal of Gastroenterology, 20, 15518-15531. https://doi.org/10.3748/wjg.v20.i42.15518
|
[21]
|
Miura, K., Kodama, Y., Inokuchi, S., et al. (2010) Toll-Like Re-ceptor 9 Promotes Steatohepatitis by Induction of Interleukin-1beta in Mice. Gastroenterology, 139, 323-234.e7. https://doi.org/10.1053/j.gastro.2010.03.052
|
[22]
|
Krajmalnik-Brown, R., et al. (2012) Effects of Gut Microbes on Nutrient Absorption and Energy Regulation. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition, 27, 201-214.
https://doi.org/10.1177/0884533611436116
|
[23]
|
Bäckhed, F., et al. (2004) The Gut Microbiota as an Environmen-tal Factor That Regulates Fat Storage. Proceedings of the National Academy of Sciences of the United States of America, 101, 15718-15723.
https://doi.org/10.1073/pnas.0407076101
|
[24]
|
Ge, H., et al. (2008) Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids. Endocrinology, 149, 4519-4526. https://doi.org/10.1210/en.2008-0059
|
[25]
|
Lorenzo-Zúñiga, V., et al. (2003) Oral Bile Acids Reduce Bacterial Overgrowth, Bacterial Translocation, and Endotoxemia in Cirrhotic Rats. Hepatology (Baltimore, Md), 37, 551-557. https://doi.org/10.1053/jhep.2003.50116
|
[26]
|
Ogata, Y., Nishi, M., Nakayama, H., et al. (2003) Role of Bile in Intestinal Barrier Function and Its Inhibitory Effect on Bacterial Translocation in Obstructive Jaundice in Rats. Journal of Surgical Research, 115, 18-23.
https://doi.org/10.1016/S0022-4804(03)00308-1
|
[27]
|
Kazankov, K., Jørgensen, S.M.D., Thomsen, K.L., et al. (2019) The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Nature Reviews Gastroenterology & Hepatology, 16, 145-159.
https://doi.org/10.1038/s41575-018-0082-x
|
[28]
|
Corbin, K.D. and Zeisel, S.H. (2012) Choline Metabolism Pro-vides Novel Insights into Nonalcoholic Fatty Liver Disease and Its Progression. Current Opinion in Gastroenterology, 28, 159-165.
https://doi.org/10.1097/MOG.0b013e32834e7b4b
|
[29]
|
Zhu, L., Baker, S.S., Gill, C., et al. (2013) Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection between Endogenous Alcohol and NASH. Hepatology, 57, 601-609.
https://doi.org/10.1002/hep.26093
|
[30]
|
Rao, R.K., Seth, A. and Sheth, P. (2004) Recent Advances in Alcoholic Liver Disease I. Role of Intestinal Permeability and Endotoxemia in Alcoholic Liver Disease. The American Journal of Physiology-Gastrointestinal and Liver Physiology, 286, G881-G884. https://doi.org/10.1152/ajpgi.00006.2004
|
[31]
|
Ferolla, S.M., Armiliato, G.N., Couto, C.A., et al. (2015) Probiotics as a Complementary Therapeutic Approach in Nonalcoholic Fatty Liver Disease. World Journal of Hepatology, 7, 559-565. https://doi.org/10.4254/wjh.v7.i3.559
|
[32]
|
Tarantino, G. and Finelli, C. (2015) Systematic Review on In-tervention with Prebiotics/Probiotics in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease. Future Microbi-ology, 10, 889-902. https://doi.org/10.2217/fmb.15.13
|
[33]
|
Madrid, A.M., Hurtado, C., Venegas, M., et al. (2001) Long-Term Treatment with Cisapride and Antibiotics in Liver Cirrhosis: Effect on Small Intestinal Motility, Bacterial Overgrowth, and Liver Function. American Journal of Gastroenterology, 96, 1251-1255. https://doi.org/10.1111/j.1572-0241.2001.03636.x
|
[34]
|
Janssen, A.W.F., Houben, T., Katiraei, S., et al. (2017) Modulation of the Gut Microbiota Impacts Nonalcoholic Fatty Liver Disease: A Potential Role for Bile Acids. Journal of Lipid Research, 58, 1399-1416.
https://doi.org/10.1194/jlr.M075713
|
[35]
|
Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., et al. (2019) Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8, 92. https://doi.org/10.3390/foods8030092
|
[36]
|
Pachikian, B.D., Essaghir, A., Demoulin, J.B., et al. (2013) Prebiotic Approach Alleviates Hepatic Steatosis: Implication of Fatty Acid Oxidative and Cholesterol Synthesis Pathways. Molec-ular Nutrition & Food Research, 57, 347-359.
https://doi.org/10.1002/mnfr.201200364
|
[37]
|
Ferolla, S.M., Couto, C.A., Costa-Silva, L., et al. (2016) Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients, 8, 397. https://doi.org/10.3390/nu8070397
|
[38]
|
Famouri, F., Shariat, Z., Hashemipour, M., et al. (2017) Effects of Probi-otics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition, 64, 413-417.
https://doi.org/10.1097/MPG.0000000000001422
|
[39]
|
Okubo, H., Sakoda, H., Kushiyama, A., et al. (2013) Lac-tobacillus casei Strain Shirota Protects against Nonalcoholic Steatohepatitis Development in a Rodent Model. The Amer-ican Journal of Physiology-Gastrointestinal and Liver Physiology, 305, G911-G918. https://doi.org/10.1152/ajpgi.00225.2013
|
[40]
|
Xin, J., Zeng, D., Wang, H., et al. (2014) Preventing Non-Alcoholic Fatty Liver Disease through Lactobacillus johnsonii BS15 by Attenuating Inflammation and Mitochondrial Injury and Improving Gut Environment in Obese Mice. Applied Microbiology and Biotechnology, 98, 6817-6829. https://doi.org/10.1007/s00253-014-5752-1
|
[41]
|
Nobili, V., Mosca, A., Alterio, T., et al. (2019) Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). Ad-vances in Experimental Medicine and Biology, 1125, 85-100. https://doi.org/10.1007/5584_2018_318
|
[42]
|
Liang, Y., Lin, C., Zhang, Y., et al. (2018) Probiotic Mixture of Lactobacillus and Bifidobacterium Alleviates Systemic Adipos-ity and Inflammation in Non-Alcoholic Fatty Liver Disease Rats through Gpr109a and the Commensal Metabolite Butyr-ate. Inflammopharmacology, 26, 1051-1055. https://doi.org/10.1007/s10787-018-0479-8
|
[43]
|
Zhou, D., Pan, Q., Shen, F., et al. (2017) Total Fecal Microbiota Transplantation Alleviates High-Fat Diet-Induced Steatohepatitis in Mice via Beneficial Regulation of Gut Microbiota. Scientific Reports, 7, Article No. 1529.
https://doi.org/10.1038/s41598-017-01751-y
|